Luu, M. http://orcid.org/0000-0002-9024-293X
Vabres, P.
Devilliers, H.
Loffroy, R.
Phan, A.
Martin, L.
Morice-Picard, F.
Petit, F.
Willems, M.
Bessis, D.
Jacquemont, M.L.
Maruani, A.
Chiaverini, C.
Mirault, T.
Clayton-Smith, J.
Carpentier, M.
Fleck, C.
Maurer, A.
Yousfi, M.
Parker, V.E.R.
Semple, R.K.
Bardou, M.
Faivre, L.
This article is maintained by: Elsevier
Article Title: Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel–Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study
Journal Title: Genetics in Medicine
CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41436-021-01290-y
Content Type: article
Copyright: © 2021, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics